| 2023-2024 |
Closure of Trading Window – June 2023 |
 |
| 2023-2024 |
Appointment of Mr. Sukesh Bhowal as CEO |
|
| 2023-2024 |
Re-appointment of Mrs. Divya Momaya as an Independent Director |
|
| 2023-2024 |
Board Meeting Intimation – April 26, 2023 |
|
| 2022-2023 |
Closure of Trading Window – March 2023 |
|
| 2022-2023 |
Details of interest or interest and principal payable during the quarter – June 2023 |
|
| 2022-2023 |
Restructuring of NCDs INE658R08180 – Coupon Reset |
|
| 2022-2023 |
Pre-mature redemption of NCDs – INE658R07422 |
|
| 2022-2023 |
Exercise of PUT option – INE658R08164 |
|
| 2022-2023 |
Board Meeting Intimation – January 23, 2023 |
|
| 2022-2023 |
Closure of Trading Window – December 2022 |
|
| 2022-2023 |
Board Meeting Intimation – October 19, 2022 |
|
| 2022-2023 |
Change in Rating by ICRA |
|
| 2022-2023 |
Appointment of Interim MD |
|
| 2022-2023 |
Board Meeting Intimation – July 27, 2022 |
|
| 2022-2023 |
Pre-mature redemption of NCDs – INE658R07331 |
|
| 2022-2023 |
Board Meeting Intimation – April 26, 2022 |
|
| 2022-2023 |
Receipt of 1st Tranche of USD 10 Million from DFC |
|
| 2021-2022 |
Annual Secretarial Compliance Report 2021-2022 |
|
| 2021-2022 |
Pre-mature redemption of NCDs – INE658R07349 |
|
| 2021-2022 |
Resignation of MD & CEO |
|
| 2021-2022 |
Intimation to Exchange about intention to raise funds |
|
| 2021-2022 |
Intimation to Exchange about intention to raise funds |
|
| 2021-2022 |
Board Meeting Intimation – January 25, 2022 |
|
| 2021-2022 |
Investors Grievance Report – December 2021 |
|
| 2021-2022 |
Board Meeting Intimation – October 27, 2021 |
|
| 2021-2022 |
Investors Grievance Report – September 2021 |
|
| 2021-2022 |
Investors Grievance Report – June 2021 |
|
| 2021-2022 |
Board Meeting Intimation – April 28, 2021 |
|
